Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: a synergistically promising approach for cell proliferation prevention and ROS-Mediated …
L Asadollahi, A Mahoutforoush, SS Dorreyatim… - International journal of …, 2022 - Elsevier
Cancer treatments are always associated with various challenges, and scientists are
constantly trying to find new therapies and methods. Erlotinib (ELT) is a well-known …
constantly trying to find new therapies and methods. Erlotinib (ELT) is a well-known …
Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
F Mokhfi, M Al Amin, M Zehravi, SH Sweilam… - Chemico-Biological …, 2024 - Elsevier
This review aims to summarize the role of alkaloids as potential modulators of the
PI3K/Akt/mTOR (PAMT) pathway in cancer therapy. The PAMT pathway plays a critical role …
PI3K/Akt/mTOR (PAMT) pathway in cancer therapy. The PAMT pathway plays a critical role …
Folic acid conjugated-chitosan modified nanostructured lipid carriers as promising carriers for delivery of Umbelliprenin to cancer cells: In vivo and in vitro
F Sadeghzadeh, A Motavalizadehkakhky… - European Polymer …, 2023 - Elsevier
The aim of this survey was to load Umbelliprenin (UMB) on nanostructured lipid carriers
(NLCs) coated with folic acid-bound chitosan and to investigate its anti-cancer effects in vitro …
(NLCs) coated with folic acid-bound chitosan and to investigate its anti-cancer effects in vitro …
Prevention of UV-induced skin cancer in mice by gamma oryzanol-loaded nanoethosomes
Aims Skin cancer is the most widespread cancer worldwide, mainly caused by exposure to
ultraviolet radiation (UV) in sunlight. Utilizing topical preventive agents in routinely daily …
ultraviolet radiation (UV) in sunlight. Utilizing topical preventive agents in routinely daily …
[PDF][PDF] Formulation of kaempferol in nanostructured lipid carriers (NLCs): a delivery platform to sensitization of MDA-MB468 breast cancer cells to paclitaxel
T Aghazadeh, N Bakhtiari, IA Rad… - Biointerface Res. Appl …, 2021 - researchgate.net
Drug delivery-based nanoparticle has been developing as a widespread innovation in
cancer treatment protocols. Here, we investigated the role of Kaempferol (KAE) loaded in …
cancer treatment protocols. Here, we investigated the role of Kaempferol (KAE) loaded in …
Harnessing Nanotechnology for Optimized Herbal Cancer Treatment: A Comprehensive Review of Nanoscale Drug Delivery Systems
MS Razavi, F Ahmadi, P Ebrahimnejad… - Pharmaceutical …, 2024 - ps.tbzmed.ac.ir
Cancer is widely recognized as the second leading cause of death on a global scale. In
recent years, nanotechnology has emerged as a promising strategy in the field of cancer …
recent years, nanotechnology has emerged as a promising strategy in the field of cancer …
Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer …
M Sabzichi, O Oladpour, J Mohammadian… - Naunyn-Schmiedeberg's …, 2021 - Springer
The aim of this study was to evaluate the potential of zoledronic acid (ZOL)-loaded lipidic
nanoparticles (ZOL-NLCs) in enhancing the efficiency of paclitaxel (Pac) in the context of …
nanoparticles (ZOL-NLCs) in enhancing the efficiency of paclitaxel (Pac) in the context of …
A convergent fabrication of programmed pH/reduction-responsive nanoparticles for efficient dual anticancer drugs delivery for ovarian cancer treatment
H Zhang, Y Yang, Y Chen, X Zhang… - Journal of Experimental …, 2023 - Taylor & Francis
A nanoparticle-based drug delivery technology could develop combination cancer therapy
more effectively. However, because of inadequate drug delivery into tumor cells, the cancer …
more effectively. However, because of inadequate drug delivery into tumor cells, the cancer …
Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective
Cancer is the uncontrolled proliferation of abnormal cells that invade other areas, spread to
other organs, and cause metastases, which is the most common cause of death. A review of …
other organs, and cause metastases, which is the most common cause of death. A review of …
Folic acid-chitosan coated stylosin nanostructured lipid carriers: fabrication, in vitro–in vivo assessment in breast malignant cells
S Sadeghi, M Homayouni Tabrizi… - Journal of Biomaterials …, 2023 - Taylor & Francis
Synthesis of targeted nanostructure lipid carriers for stylosin (STY-CFN-NPs) delivery to
MCF-7 cells. STY-CFN-NPs were formulated via the homogenization and ultra-sonication …
MCF-7 cells. STY-CFN-NPs were formulated via the homogenization and ultra-sonication …